ACADIA Pharmaceuticals (ACAD) Analyst & Key Data

Analyst Consensus

Buy25 analysts

Buy

Updated Sep 12, 2026

Total Analysts25

Buy

26

Hold

10

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$27.83

Median Target+20.09%

$33.42

Potential upside vs current price

DCF Value-213.29%

-$31.53

Potential downside vs current price

Current Stock Price

$27.83

Median Target+20.09%

$33.42

Potential upside vs current price

DCF Value-213.29%

-$31.53

Potential downside vs current price

Analyst Consensus

Buy25 analysts

Buy

Updated Sep 12, 2026

Total Analysts25

Buy

26

Hold

10

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$27.83

Median Target+20.09%

$33.42

Potential upside vs current price

DCF Value-213.29%

-$31.53

Potential downside vs current price

Current Stock Price

$27.83

Median Target+20.09%

$33.42

Potential upside vs current price

DCF Value-213.29%

-$31.53

Potential downside vs current price

ACADIA Pharmaceuticals Inc.